NCT04489186 is a NA clinical trial of Wearable device in Cystic Fibrosis, sponsored by Byteflies.

Who is sponsoring NCT04489186?

NCT04489186 is sponsored by Byteflies.

What drugs are being tested in NCT04489186?

Interventions in NCT04489186: Wearable device.

What condition does NCT04489186 study?

NCT04489186 studies Cystic Fibrosis.

Is NCT04489186 still recruiting?

NCT04489186 is currently completed. Last updated 28 July 2020.

Last reviewed 2020-07-28 · How we verify

NCT04489186

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Cardiorespiratory Monitoring in Cystic Fibrosis

Completed NA Last updated 28 July 2020

What this trial tests

NA trial testing Wearable device in Cystic Fibrosis in 26 participants. Completed in 31 December 2019.

Timeline

1 December 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Byteflies
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	26
Start date	1 December 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

Wearable device

Conditions studied

Cystic Fibrosis — all drugs for Cystic Fibrosis →

Sponsor

Byteflies

Who can join

18 and older, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cystic Fibrosis (CF) is a disease without a primary cure that requires lifelong care and is characterized by pulmonary exacerbations (PEx). Wearable devices could provide a way for long-term monitoring of disease progression and early signs of PEx to intervene as early as possible, thereby improving long-term outcomes. This in-hospital feasibility study will assess the ability of Byteflies Sensor Dots to collect relevant cardiorespiratory data in people with CF and its compatibility with clinical workflows, 2) identify candidate digital biomarkers, and 3) collect user feedback from patients and healthcare providers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Wearable device

Trials testing the same drug.

NCT06887387 — Wearable Devices for Patient Monitoring in Long QT Syndrome · recruiting
NCT06538155 — Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation · recruiting
NCT05741112 — The Long COVID-19 Wearable Device Study · NA · recruiting
NCT05173870 — Remote Monitoring to Prevent Frailty Progression in the Elderly · terminated
NCT04736576 — Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Brea · NA · completed

Other recruiting trials for Cystic Fibrosis

Currently open trials in the same condition.

NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting

Other Byteflies trials

Trials by the same sponsor.

NCT07225231 — Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS · NA · not yet recruiting
NCT05738226 — EpiCare@Home Validation Study for Focal Onset Seizures · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04489186 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Byteflies
Last refreshed: 28 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04489186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing